These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 15099753)

  • 1. Construction and characterization of monoclonal antibodies specific to Epstein-Barr virus latent membrane protein 1.
    Fang CY; Chang YS; Chow KP; Yu JS; Chang HY
    J Immunol Methods; 2004 Apr; 287(1-2):21-30. PubMed ID: 15099753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction and characterization of monoclonal antibodies specific for the R transactivator 185 of Epstein-Barr virus.
    Zhu YH; Wei YS; Li H; Liang WB; Du B; Zhang GQ; Zhang L
    J Virol Methods; 2007 Sep; 144(1-2):12-6. PubMed ID: 17532480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-Barr virus latent membrane protein does not inhibit differentiation and induces tumorigenicity of human epithelial cells.
    Nicholson LJ; Hopwood P; Johannessen I; Salisbury JR; Codd J; Thorley-Lawson D; Crawford DH
    Oncogene; 1997 Jul; 15(3):275-83. PubMed ID: 9233762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of Epstein-Barr virus latent membrane protein 1 activity by intrabodies.
    Fang CY; Chiang CY; Pan YR; Tse KP; Chang YS; Chang HY
    Intervirology; 2007; 50(4):254-63. PubMed ID: 17460414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal antibodies to the latent membrane protein of Epstein-Barr virus reveal heterogeneity of the protein and inducible expression in virus-transformed cells.
    Rowe M; Evans HS; Young LS; Hennessy K; Kieff E; Rickinson AB
    J Gen Virol; 1987 Jun; 68 ( Pt 6)():1575-86. PubMed ID: 2438376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant adeno-associated virus mediated RNA interference inhibits metastasis of nasopharyngeal cancer cells in vivo and in vitro by suppression of Epstein-Barr virus encoded LMP-1.
    Li X; Liu X; Li CY; Ding Y; Chau D; Li G; Kung HF; Lin MC; Peng Y
    Int J Oncol; 2006 Sep; 29(3):595-603. PubMed ID: 16865275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Native early antigen of Epstein-Barr virus, a promising antigen for diagnosis of nasopharyngeal carcinoma.
    Paramita DK; Fachiroh J; Artama WT; van Benthem E; Haryana SM; Middeldorp JM
    J Med Virol; 2007 Nov; 79(11):1710-21. PubMed ID: 17854043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Telomerase activation by Epstein-Barr virus latent membrane protein 1 is associated with c-Myc expression in human nasopharyngeal epithelial cells.
    Yang J; Deng X; Deng L; Gu H; Fan W; Cao Y
    J Exp Clin Cancer Res; 2004 Sep; 23(3):495-506. PubMed ID: 15595642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell therapy of stage IV nasopharyngeal carcinoma with autologous Epstein-Barr virus-targeted cytotoxic T lymphocytes.
    Comoli P; Pedrazzoli P; Maccario R; Basso S; Carminati O; Labirio M; Schiavo R; Secondino S; Frasson C; Perotti C; Moroni M; Locatelli F; Siena S
    J Clin Oncol; 2005 Dec; 23(35):8942-9. PubMed ID: 16204009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal antibodies recognizing EVETPIRN epitope of influenza A virus M2 protein could protect mice from lethal influenza A virus challenge.
    Liu W; Zou P; Chen YH
    Immunol Lett; 2004 May; 93(2-3):131-6. PubMed ID: 15158608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decoy receptor 3, upregulated by Epstein-Barr virus latent membrane protein 1, enhances nasopharyngeal carcinoma cell migration and invasion.
    Ho CH; Chen CL; Li WY; Chen CJ
    Carcinogenesis; 2009 Aug; 30(8):1443-51. PubMed ID: 19483191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Recombinant AAV-LMP-induced LMP specific cytotoxic response to autologous lymphoblastoid cell lines tranformed by Epstein-Barr virus].
    Zhao F; Liu H; Zhou L; Cai W; Du B; Ye S; Zeng Y
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Sep; 11(3):247-51. PubMed ID: 15617340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Construction of three transgenic vectors carrying the latent membrane protein gene of Epstein-Barr virus].
    Xiao Z; Guan Y; Duan C; Chen Z; Yao K
    Hunan Yi Ke Da Xue Xue Bao; 1999; 24(1):1-4. PubMed ID: 11938726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Production and characterization of monoclonal antibodies against binary ethylenimine inactivated Nipah virus.
    Berhane Y; Berry JD; Ranadheera C; Marszal P; Nicolas B; Yuan X; Czub M; Weingartl H
    J Virol Methods; 2006 Mar; 132(1-2):59-68. PubMed ID: 16226320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular diagnosis of nasopharyngeal carcinoma using detection of Epstein-Barr virus latent membrane protein-1 gene in cervical metastatic lymph nodes.
    Khademi B; Mahmoudi J; Monabati A; Maghsoudi B; Ashraf MJ; Mohammadianpanah M; Tabibi N; Valibeigi B; Abedi E
    Am J Otolaryngol; 2009; 30(2):95-100. PubMed ID: 19239950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional assays of HLA A2-restricted epitope variant of latent membrane protein 1 (LMP-1) of Epstein-Barr virus in nasopharyngeal carcinoma of Southern China and Taiwan.
    Lin HJ; Cherng JM; Hung MS; Sayion Y; Lin JC
    J Biomed Sci; 2005 Dec; 12(6):925-36. PubMed ID: 16307312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of monoclonal antibodies of desired specificity using chimeric polyomavirus-derived virus-like particles.
    Zvirbliene A; Samonskyte L; Gedvilaite A; Voronkova T; Ulrich R; Sasnauskas K
    J Immunol Methods; 2006 Apr; 311(1-2):57-70. PubMed ID: 16516908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of Luminex xMAP-derived Bio-Plex bead-based suspension array for specific detection of PPV W and characterization of epitopes on the coat protein of the virus.
    Croft H; Malinowski T; Krizbai L; Mikec I; Kajic V; Reed C; Varga A; James D
    J Virol Methods; 2008 Nov; 153(2):203-13. PubMed ID: 18722476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Possible Effect of B-Cell Epitopes of Epstein-Barr Virus Early Antigen, Membrane Antigen, Latent Membrane Protein-1, and -2A on Systemic Lupus Erythematosus.
    Tu J; Wang X; Geng G; Xue X; Lin X; Zhu X; Sun L
    Front Immunol; 2018; 9():187. PubMed ID: 29497417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein-Barr virus (EBV) latent membrane protein 1 induces interleukin-8 through the nuclear factor-kappa B signaling pathway in EBV-infected nasopharyngeal carcinoma cell line.
    Ren Q; Sato H; Murono S; Furukawa M; Yoshizaki T
    Laryngoscope; 2004 May; 114(5):855-9. PubMed ID: 15126743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.